Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001209191-23-010045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-16 | 2023-02-14 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $298.70 | -6,398 | 50.2K | -11% | -$1.91M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 842 | $296.85 | 52,754 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.42 to $297.37). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-02-14 | S | D | 1,888 | $300.11 | 48,306 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $300.11 (range $299.76 to $300.70). |
| 3 | Common | Common Stock | 2023-02-14 | S | D | 800 | $295.79 | 53,596 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $295.79 (range $295.31 to $296.12). |
| 4 | Common | Common Stock | 2023-02-14 | S | D | 308 | $301.02 | 47,998 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $301.02 (range $300.79 to $301.22). |
| 5 | Common | Common Stock | 2023-02-14 | S | D | 395 | $297.97 | 52,359 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $297.97 (range $297.50 to $298.35). |
| 6 | Common | Common Stock | 2023-02-14 | S | D | 2,165 | $299.08 | 50,194 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $299.08 (range $298.71 to $299.54). |